JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 10, 2003; DOI: 10.1124/jpet.103.057570


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.057570v1
308/2/760    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Fiona R. Coulson
David B. Jacoby
Allison D. Fryer
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coulson, F. R.
Right arrow Articles by Fryer, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coulson, F. R.
Right arrow Articles by Fryer, A. D.


Received for publication September 5, 2003.
Revised October 28, 2003.
Accepted for publication November 4, 2003.

Insulin regulates neuronal M2 muscarinic receptor function in the ileum of diabetic rats

Fiona R. Coulson 1*, David B. Jacoby 1, Allison D. Fryer 1

1 Johns Hopkins Bloomberg School of Public Health

* Address correspondence to: E-mail: f.coulson{at}griffith.edu.au

Abstract

Acetylcholine release from cholinergic nerves in the gastrointestinal tract is limited by neuronal M2 muscarinic receptors. In diabetic animals, M2 muscarinic receptor function in the ileum is increased leading to decreased acetylcholine release and smooth muscle contraction in response to nerve stimulation. The mechanisms responsible for increased M2 muscarinic receptor function are unknown but may contribute to the gastrointestinal dysmotility that occurs frequently in diabetics. In this study, we investigated whether insulin modulates M2 muscarinic receptor function in the gastrointestinal tract of diabetic rats. M2 muscarinic receptor function was tested by measuring the ability of an agonist, pilocarpine, to inhibit and an antagonist, methoctramine, to potentiate electrical field stimulation (EFS)-induced contraction of ileum in vitro. Insulin administration (0.2, 0.6, 2U s.c. daily for seven days) reversed the diabetes-induced increase in M2 muscarinic receptor function and restored normal contractions to EFS. Insulin had no effect on the function of post-junctional M3 muscarinic receptors, determined by measuring contractile responses to acetylcholine. These data suggest that insulin tonically inhibits neuronal M2 muscarinic receptors. Thus, loss of insulin removes this inhibition and increases M2 muscarinic receptor function leading to decreased acetylcholine release and contraction to EFS. In non-diabetic rats, there was a trend that higher insulin doses (0.6, 2U) increased M2 muscarinic receptor function suggesting a bell-shaped concentration-response relationship for insulin. In conclusion, lack of insulin or excess insulin increases M2 muscarinic receptor function in rat ileum. This mechanism may contribute to decreased acetylcholine release in the gastrointestinal tract of diabetics, resulting in dysmotility.


Key words: Acetylcholine, Diabetes, Dysmotility, Parasympathetic nerves, Small intestine, Smooth muscle





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.